![Chong Xu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Chong Xu
Directeur/Membre du Conseil chez
K36 Therapeutics, Inc.
Profil
Chong Xu is currently Director at Geneception, Inc., K36 Therapeutics, Inc., and Shanghai Rarestone Health Tech Group Co., Ltd., and Partner at F-Prime, Inc. since 2015.
Former roles include Director at Adagene, Inc. from 2020 to 2021, Equity Analyst at Massif Partners Holdings LP, Associate at McKinsey & Co., Inc., Analyst at Affirmed Capital LLC, and Principal at Eight Roads Ventures Japan.
Education includes a doctorate from the University of Virginia in 2009, an undergraduate degree from Zhejiang University in 2001, and an MBA from the University of Virginia Darden School of Business in 2014.
Postes actifs de Chong Xu
| Sociétés | Poste | Début |
|---|---|---|
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Private Equity Investor | - |
Geneception, Inc.
 Geneception, Inc. BiotechnologyHealth Technology Engages in research and development of biotechnology products | Directeur/Membre du Conseil | - |
K36 Therapeutics, Inc.
 K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Directeur/Membre du Conseil | - |
Shanghai Rarestone Health Tech Group Co. Ltd.
 Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Directeur/Membre du Conseil | - |
Anciens postes connus de Chong Xu
| Sociétés | Poste | Fin |
|---|---|---|
| ADAGENE INC. | Directeur/Membre du Conseil | 08/02/2021 |
Eight Roads Ventures Japan
 Eight Roads Ventures Japan Investment ManagersFinance Eight Roads Ventures Japan invests in companies located in Japan. The firm targets companies operating in the fields of consumer, enterprise, fintech, healthcare services, pharma & therapeutics and med tech sectors. It provides financing for early and growth stage capital requirements. | Corporate Officer/Principal | - |
Massif Partners Holdings LP
 Massif Partners Holdings LP Financial ConglomeratesFinance Functions as a investment fund | Corporate Officer/Principal | - |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Corporate Officer/Principal | - |
Affirmed Capital LLC
 Affirmed Capital LLC Investment ManagersFinance Affirmed Capital invests primarily in the health services and health technology sectors. They invest globally across all market-caps | Analyst-Equity | - |
Formation de Chong Xu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
93
Relations au 1er degré
12
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 12 |
|---|---|
Massif Partners Holdings LP
Massif Partners Holdings LP Financial ConglomeratesFinance Functions as a investment fund | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
Zhejiang University
 Zhejiang University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Affirmed Capital LLC
Affirmed Capital LLC Investment ManagersFinance Affirmed Capital invests primarily in the health services and health technology sectors. They invest globally across all market-caps | Finance |
Adagene, Inc.
 Adagene, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which discovers and develops novel antibody-based cancer immunotherapies | Health Technology |
Eight Roads Ventures Japan
Eight Roads Ventures Japan Investment ManagersFinance Eight Roads Ventures Japan invests in companies located in Japan. The firm targets companies operating in the fields of consumer, enterprise, fintech, healthcare services, pharma & therapeutics and med tech sectors. It provides financing for early and growth stage capital requirements. | Finance |
University of Virginia Darden School of Business
 University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Impresa Management LLC
Impresa Management LLC Investment ManagersFinance F-Prime invests in companies located in Asia, Europe, North America and South America. The firm targets companies operating in the fields of life sciences, technology, healthtech & services and crypto sectors. It provides financing for seed, early and later stage transactions. | Finance |
Geneception, Inc.
Geneception, Inc. BiotechnologyHealth Technology Engages in research and development of biotechnology products | Health Technology |
K36 Therapeutics, Inc.
K36 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule therapeutics | Health Technology |
Shanghai Rarestone Health Tech Group Co. Ltd.
Shanghai Rarestone Health Tech Group Co. Ltd. Pharmaceuticals: MajorHealth Technology Develops and supplies rare disease pharmaceutical products & provides medical services | Health Technology |
